However, the existing data in the literature on the relationship between IL-15 and B-CLL are extremely contradictory, and IL-15 could be considered a new agent that is able to ameliorate the effect of immunotherapy. This evidence concerns the gene IL15 and B-cell chronic lymphocytic leukemia.